Accurate kinetic modelling of in vivo physiological function using positron emission tomography 10
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MRI of mice
Accurate kinetic modelling of in vivo physiological function using positron emission tomography 10 (PET) requires determination of the tracer time-activity curve in plasma, known as the arterial input 11 function (AIF). The AIF is usually determined by invasive blood sampling methods, which are 12 prohibitive in murine studies due to low total blood volumes. Extracting AIFs from PET images is 13 also challenging due to large partial volume effects (PVE). We hypothesise that in combined PET 14 with magnetic resonance imaging (PET/MR), a co-injected bolus of MR contrast agent and PET 15 ligand can be tracked using fast MR acquisitions. This protocol would allow extraction of a MR AIF 16 from MR contrast agent concentration-time curves, at higher spatial and temporal resolution than an 17 image-derived PET AIF. A conversion factor could then be applied to the MR AIF for use in PET effects (PVE) contaminate the measurements, typically reducing the peak height and increasing the 42 width of the AIF peak [7] . As yet, no consensus has been achieved in preclinical studies for the 43 extraction of image-derived AIFs accurately and reliably.
44
Simultaneous PET/MR can be used to combine the comparatively high temporal and spatial 45 resolution of dynamic MRI imaging to assist in non-invasive AIF extraction from dynamic PET. We 46 hypothesise that a co-injected bolus of MR contrast agent and PET ligand can be tracked with fast MR 47
acquisitions. This protocol would allow extraction of a MR AIF from MR contrast agent 48 concentration-time curves which could then be converted to a PET AIF for use in kinetic analysis. 49
The concentration-time curve of a gadolinium-based MR contrast agent has previously been used 50 to model PET tracer TACs in plasma [8] . The MR and PET AIFs analysed by Poulin et al. were found 51 to adopt a similar shape in the first pass but diverge in the long decay phase. The conversion between 52 MR and PET AIFs therefore had to be conducted via empirically-derived factors for the rodent cohort. 53
In the present study, we have focused on the first pass bolus of the tracer to ascertain how similar 54 the contrast agent and tracer curves are between modalities in the initial injection phase. Echo planar 55 imaging (EPI) sequences have been used in a dynamic susceptibility contrast (DSC)-MRI protocol [9] 56 to detect the passage of contrast agent through murine arteries and veins via a change in the R2* 57 relaxation parameter, which is proportional to the change in gadolinium-based contrast agent. 58
It is difficult, however, to reliably identify blood vessel voxels in DSC-MRI due to the low SNR 59 of EPI acquisitions. Manually selecting voxels to extract an AIF is therefore vulnerable to human 60 error and low reproducibility [10] . angiography scans was used to create a voxelwise probability map for murine blood vessels 86 (256×256×128, isotropic resolution 250μm, thickness 0.2mm). The processing and transformation of 87 the prior knowledge map into mouse native space is shown in Figure 2 . This map was transformed to 88 each subject using the SPMmouse toolbox [19] . 89 90
INSERT FIGURE 2 (1 column width) 91 92
A rectangular ROI which encompassed the posterior cerebral artery (PCA) was selected as a 93 starting point for an iterative voxel selection algorithm. AIF characteristics were ranked and starting 94 threshold values determined empirically for each parameter. The algorithm applied the following 95 steps to the MR contrast agent concentration-time curves: 96
Step 1) Select voxels in ROI with rise time <3s 97
Step 2) Peak height > 90 th percentile 98
Step 3) Area under the curve (AUC) >10 th percentile and first moment <50 th percentile 99
Step 4) FWHM < 50 th percentile 100
Prior knowledge from the vascular atlas was then applied, selecting voxels with a probability >0.2 101 of being a major blood vessel. The thresholding method was then re-applied, iteratively adjusting the 102 threshold values (e.g. changing 90 th to 95 th percentile for peak height threshold) for each mouse until 103 <10 voxels remained. The application of this algorithm is illustrated in Figure 3 . 104
INSERT FIGURE 3 (2 column width) AND FIGURE 4 (1 column width) 106 107
AIF comparison MR AIFs were extracted as the mean signal from 5 voxels with the largest signal 108 heights which survived all thresholds. For the PET data, a volume of interest (VOI) for the left 109 ventricle was drawn on the final frame of each dataset using a manually seeded growth algorithm in 110 the ASIPro software provided with the scanner (Siemens Medical Solutions, USA, Inc., Knoxville, 111 TN, USA). These VOIs were projected onto all frames and PET AIFs were extracted as the mean 112 signal from the VOI in each frame, as shown in Figure 4 . 113 PET and MR AIFs were compared by aligning the flush peaks of the curves and normalizing the 114 areas under curves (AUC) for the first 90s or setting the peak heights to 1. MR AIF data was also 115 averaged into the PET temporal resolution and compared to the PET curves. Curve Comparisons Gamma variate fits were successfully performed on both MR and PET AIFs 126 and are shown in Figure 4 for the AUC normalization. Goodness of fit was confirmed with p values 127 <0.02 using the Chi-squared test. Increased agreement between the curves (see Figure 5 ) was seen as 128 the peak height of the MR AIFs was reduced after averaging the MR AIF data into the PET temporal 129 resolution. Figure 6 shows the MR (6(a)) and PET ( The MR AIFs show that preclinical AIFs are improved in a similar manner to clinical AIFs if 138 voxel selection is automated [11-13]. The decreased variation in the MR AIFs after application of 139 prior knowledge derived from angiography recommends the use of the algorithm in future studies.
140
Whilst similar shapes are confirmed in the first pass by fitting gamma variate functions, the peaks 141 of the first pass were much taller and thinner from the MR AIFs when compared to the PET AIFs in 142 the AUC normalization. This was confirmed by the peak height normalization, where the tails of the 143
PET curves remained at a much higher level over the course of the scan. Both normalizations show 144 similar arterial characters in the peak region but differences seen between the curves appear 145 characteristic of PVE in the PET data. This difference was still observed if the MR data (0.25s 146 resolution) were smoothed into the PET temporal resolution of 1s. The difference between the curves 147 was attributed to contaminating the AIF with tissue TACs, resulting in the apparent lower peak height.
148
Whilst these results are encouraging, it must be noted that there was variability between the PET 149 curves due to different volumes of tracer being injected and additional variability in both sets of 150 curves due to manual administrations of the bolus injections. These obstacles could be avoided in 151 future experiments with a syringe pump and a co-injection of tracer and contrast agent to ensure that 152 the MR and PET protocols truly measure the same AIF. 
